title: Chest Imaging.
abstract: Chest imaging has a central role in the diagnosis and monitoring of sarcoidosis. For staging of pulmonary disease on chest radiograph, Scadding stages are still widely used. High-resolution CT (HRCT), however, is more accurate in visualizing the various manifestations of pulmonary sarcoidosis as well its complications. A generally accepted HRCT scoring system is lacking. Fluorodeoxyglucose F 18 positron emission tomography can visualize disease activity better than conventional makers in a significant proportion of patients. In patients with extensive changes on HRCT but no parenchymal fluorodeoxyglucose F 18 uptake, prudence with regard to initiation or intensification of immunosuppressive treatment is warranted.
authors.affiliation: Department of Nuclear Medicine, St. Antonius Hospital, Koekoekslaan 1, Utrecht, Nieuwegein 3435 CM, The Netherlands.
authors.forename: Ruth G
authors.initials: RG
authors.lastname: Keijsers
authors.affiliation: ILD Center of Excellence, St. Antonius Hospital, Koekoekslaan 1, Utrecht, Nieuwegein 3435 CM, The Netherlands.
authors.forename: Marcel
authors.initials: M
authors.lastname: Veltkamp
authors.affiliation: ILD Center of Excellence, St. Antonius Hospital, Koekoekslaan 1, Utrecht, Nieuwegein 3435 CM, The Netherlands; Division of Heart and Lungs, University Medical Center, Utrecht, The Netherlands. Electronic address: j.grutters@antoniusziekenhuis.nl.
authors.forename: Jan C
authors.initials: JC
authors.lastname: Grutters
mesh_terms: D019788:Fluorodeoxyglucose F18 / Q000378:metabolism*; D006801:Humans; D049268:Positron-Emission Tomography / Q000379:methods*; D012507:Sarcoidosis / Q000000981:diagnostic imaging*; D014057:Tomography, X-Ray Computed / Q000379:methods*
chemical_list: D019788:Fluorodeoxyglucose F18
keywords: Chest radiography; Disease activity; FDG PET/CT; HRCT; Sarcoidosis